Use and interpretation of diagnostic vaccination in primary immunodeficiency

A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

Jordan S. Orange, Mark Ballow, E. Richard Stiehm, Zuhair K. Ballas, Javier Chinen, Maite De La Morena, Dinakantha Kumararatne, Terry O. Harville, Paul Hesterberg, Majed Koleilat, Sean McGhee, Elena E. Perez, Jason Raasch, Rebecca Scherzer, Harry Schroeder, Christine Seroogy, Aarnoud Huissoon, Ricardo U. Sorensen, Rohit Katial

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

A major diagnostic intervention in the consideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the application and interpretation of vaccination. Specifically, the antibody response to antigenic challenge with vaccines can provide substantive insight into the status of human immune function. There are numerous vaccines that are commonly used in healthy individuals, as well as others that are available for specialized applications. Both can potentially be used to facilitate consideration of PIDD. However, the application of vaccines and interpretation of antibody responses in this context are complex. These rely on consideration of numerous existing specific studies, interpolation of data from healthy populations, current diagnostic guidelines, and expert subspecialist practice. This document represents an attempt of a working group of the American Academy of Allergy, Asthma & Immunology to provide further guidance and synthesis in this use of vaccination for diagnostic purposes in consideration of PIDD, as well as to identify key areas for further research.

Original languageEnglish
JournalJournal of Allergy and Clinical Immunology
Volume130
Issue number3 SUPPL.
DOIs
StatePublished - Sep 1 2012

Fingerprint

Allergy and Immunology
Hypersensitivity
Vaccination
Vaccines
Asthma
Antibody Formation
Guidelines
Research
Population

Keywords

  • antibody deficiency
  • antigen challenge
  • common variable immunodeficiency
  • diagnosis
  • guideline
  • neoantigen
  • primary immunodeficiency
  • specific antibody deficiency
  • Vaccines

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Use and interpretation of diagnostic vaccination in primary immunodeficiency : A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. / Orange, Jordan S.; Ballow, Mark; Stiehm, E. Richard; Ballas, Zuhair K.; Chinen, Javier; De La Morena, Maite; Kumararatne, Dinakantha; Harville, Terry O.; Hesterberg, Paul; Koleilat, Majed; McGhee, Sean; Perez, Elena E.; Raasch, Jason; Scherzer, Rebecca; Schroeder, Harry; Seroogy, Christine; Huissoon, Aarnoud; Sorensen, Ricardo U.; Katial, Rohit.

In: Journal of Allergy and Clinical Immunology, Vol. 130, No. 3 SUPPL., 01.09.2012.

Research output: Contribution to journalArticle

Orange, JS, Ballow, M, Stiehm, ER, Ballas, ZK, Chinen, J, De La Morena, M, Kumararatne, D, Harville, TO, Hesterberg, P, Koleilat, M, McGhee, S, Perez, EE, Raasch, J, Scherzer, R, Schroeder, H, Seroogy, C, Huissoon, A, Sorensen, RU & Katial, R 2012, 'Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology', Journal of Allergy and Clinical Immunology, vol. 130, no. 3 SUPPL.. https://doi.org/10.1016/j.jaci.2012.07.002
Orange, Jordan S. ; Ballow, Mark ; Stiehm, E. Richard ; Ballas, Zuhair K. ; Chinen, Javier ; De La Morena, Maite ; Kumararatne, Dinakantha ; Harville, Terry O. ; Hesterberg, Paul ; Koleilat, Majed ; McGhee, Sean ; Perez, Elena E. ; Raasch, Jason ; Scherzer, Rebecca ; Schroeder, Harry ; Seroogy, Christine ; Huissoon, Aarnoud ; Sorensen, Ricardo U. ; Katial, Rohit. / Use and interpretation of diagnostic vaccination in primary immunodeficiency : A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. In: Journal of Allergy and Clinical Immunology. 2012 ; Vol. 130, No. 3 SUPPL.
@article{4fa02d62b37a4f8cb1e9a300536ce310,
title = "Use and interpretation of diagnostic vaccination in primary immunodeficiency: A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology",
abstract = "A major diagnostic intervention in the consideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the application and interpretation of vaccination. Specifically, the antibody response to antigenic challenge with vaccines can provide substantive insight into the status of human immune function. There are numerous vaccines that are commonly used in healthy individuals, as well as others that are available for specialized applications. Both can potentially be used to facilitate consideration of PIDD. However, the application of vaccines and interpretation of antibody responses in this context are complex. These rely on consideration of numerous existing specific studies, interpolation of data from healthy populations, current diagnostic guidelines, and expert subspecialist practice. This document represents an attempt of a working group of the American Academy of Allergy, Asthma & Immunology to provide further guidance and synthesis in this use of vaccination for diagnostic purposes in consideration of PIDD, as well as to identify key areas for further research.",
keywords = "antibody deficiency, antigen challenge, common variable immunodeficiency, diagnosis, guideline, neoantigen, primary immunodeficiency, specific antibody deficiency, Vaccines",
author = "Orange, {Jordan S.} and Mark Ballow and Stiehm, {E. Richard} and Ballas, {Zuhair K.} and Javier Chinen and {De La Morena}, Maite and Dinakantha Kumararatne and Harville, {Terry O.} and Paul Hesterberg and Majed Koleilat and Sean McGhee and Perez, {Elena E.} and Jason Raasch and Rebecca Scherzer and Harry Schroeder and Christine Seroogy and Aarnoud Huissoon and Sorensen, {Ricardo U.} and Rohit Katial",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.jaci.2012.07.002",
language = "English",
volume = "130",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "3 SUPPL.",

}

TY - JOUR

T1 - Use and interpretation of diagnostic vaccination in primary immunodeficiency

T2 - A working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology

AU - Orange, Jordan S.

AU - Ballow, Mark

AU - Stiehm, E. Richard

AU - Ballas, Zuhair K.

AU - Chinen, Javier

AU - De La Morena, Maite

AU - Kumararatne, Dinakantha

AU - Harville, Terry O.

AU - Hesterberg, Paul

AU - Koleilat, Majed

AU - McGhee, Sean

AU - Perez, Elena E.

AU - Raasch, Jason

AU - Scherzer, Rebecca

AU - Schroeder, Harry

AU - Seroogy, Christine

AU - Huissoon, Aarnoud

AU - Sorensen, Ricardo U.

AU - Katial, Rohit

PY - 2012/9/1

Y1 - 2012/9/1

N2 - A major diagnostic intervention in the consideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the application and interpretation of vaccination. Specifically, the antibody response to antigenic challenge with vaccines can provide substantive insight into the status of human immune function. There are numerous vaccines that are commonly used in healthy individuals, as well as others that are available for specialized applications. Both can potentially be used to facilitate consideration of PIDD. However, the application of vaccines and interpretation of antibody responses in this context are complex. These rely on consideration of numerous existing specific studies, interpolation of data from healthy populations, current diagnostic guidelines, and expert subspecialist practice. This document represents an attempt of a working group of the American Academy of Allergy, Asthma & Immunology to provide further guidance and synthesis in this use of vaccination for diagnostic purposes in consideration of PIDD, as well as to identify key areas for further research.

AB - A major diagnostic intervention in the consideration of many patients suspected to have primary immunodeficiency diseases (PIDDs) is the application and interpretation of vaccination. Specifically, the antibody response to antigenic challenge with vaccines can provide substantive insight into the status of human immune function. There are numerous vaccines that are commonly used in healthy individuals, as well as others that are available for specialized applications. Both can potentially be used to facilitate consideration of PIDD. However, the application of vaccines and interpretation of antibody responses in this context are complex. These rely on consideration of numerous existing specific studies, interpolation of data from healthy populations, current diagnostic guidelines, and expert subspecialist practice. This document represents an attempt of a working group of the American Academy of Allergy, Asthma & Immunology to provide further guidance and synthesis in this use of vaccination for diagnostic purposes in consideration of PIDD, as well as to identify key areas for further research.

KW - antibody deficiency

KW - antigen challenge

KW - common variable immunodeficiency

KW - diagnosis

KW - guideline

KW - neoantigen

KW - primary immunodeficiency

KW - specific antibody deficiency

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84862865305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862865305&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2012.07.002

DO - 10.1016/j.jaci.2012.07.002

M3 - Article

VL - 130

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 3 SUPPL.

ER -